News

ABLE member Aurobindo arm CuraTeQ successfully wraps up Ph 1 trial for Omalizumab biosimilar

The primary objective was to prove pharmacokinetic (PK) equivalence between BP11, US and EU sourced Xolair.

Read More

Mar 15, 2024

By : Team ABLE

ABLE member Biocon Biologics, Eris Lifesciences Collaborate to Enhance Patient Access in India

CEO Shreehas Tambe highlights the commitment to delivering high-quality biosimilars to millions of Indian patients.

Read More

Mar 14, 2024

By : Team ABLE

ICT Mumbai SATHI FOUNDATION (Mumbai Biocluster) Awarded Rs 60 Crore for Accelerating Biopharmaceutical Innovation

The biocluster will serve as an accelerator for startups, academia, MSMEs, and industries, providing state-of-the-art infrastructure and expertise for faster development of biopharmaceutical products.

Read More

Mar 07, 2024

By : Team ABLE

ABLE member Biocon Biologics Finalizes Agreement for US Launch of Stelara Biosimilar Bmab 1200

Biocon Biologics has reached a significant milestone with the finalization of a settlement and license agreement with Janssen Biotech Inc. and Johnson & Johnson.

Read More

Mar 01, 2024

By : Team ABLE

ABLE member Thermo Fisher Scientific Partners with Atal Incubation Centre to Boost Innovation

Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB) in Hyderabad has inked an agreement with ABLE member Thermo Fisher Scientific.

Read More

Jan 31, 2024

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights